Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Change in Cash (2018 - 2025)

Historic Change in Cash for Serina Therapeutics (SER) over the last 8 years, with Q3 2025 value amounting to $2.6 million.

  • Serina Therapeutics' Change in Cash rose 18957.97% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 22390.7%. This contributed to the annual value of -$3.9 million for FY2024, which is 15569.35% down from last year.
  • According to the latest figures from Q3 2025, Serina Therapeutics' Change in Cash is $2.6 million, which was up 18957.97% from $1.8 million recorded in Q2 2025.
  • Serina Therapeutics' 5-year Change in Cash high stood at $9.4 million for Q1 2023, and its period low was -$2.9 million during Q3 2024.
  • Its 5-year average for Change in Cash is $431894.7, with a median of $116000.0 in 2021.
  • Examining YoY changes over the last 5 years, Serina Therapeutics' Change in Cash showed a top increase of 699705.88% in 2023 and a maximum decrease of 56850.39% in 2023.
  • Quarter analysis of 5 years shows Serina Therapeutics' Change in Cash stood at -$147000.0 in 2021, then soared by 221.77% to $179000.0 in 2022, then crashed by 78.77% to $38000.0 in 2023, then skyrocketed by 1050.0% to $437000.0 in 2024, then skyrocketed by 490.16% to $2.6 million in 2025.
  • Its Change in Cash was $2.6 million in Q3 2025, compared to $1.8 million in Q2 2025 and $595000.0 in Q1 2025.